Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

Agilent Technologies Announces Microarray Certified Service Provider in Korea

Wednesday, September 16, 2009
 Email This |  Printer Friendly

Agilent Technologies has announced that DNA Link has achieved Certified Service Provider status for Agilent microarray platform. The certification is for array-based comparative genomic hybridization (aCGH) and microRNA (miRNA) applications, both representing growing segments for the Agilent genomics business.

aCGH measures chromosomal duplications and deletions, while miRNA is a class of small non-coding RNAs estimated to regulate about 30 percent of all human genes. Both are implicated in regulating gene expression and function in relating to human diseases.

Recently, an international team led by researchers at Seoul National University had published a breakthrough study using custom-designed Agilent CGH array to sequence the entire gene map of a Korean male.

"DNA Link is the first Agilent certified service provider in Korea. It has established facility and well-trained staff to support our expanding applications and customer base in Korea," said Dr. Chris Tan, Agilent director of sales, genomics and life sciences, Asia Pacific and Japan. "We will continue to seek further collaboration with the region's top genomic players to respond to the growing market's needs. "


Share this:   Del.icio.us | 
Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy